<DOC>
	<DOCNO>NCT01698554</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost solution formulation A compare bimatoprost solution 0.03 % ( LATISSEÂ® ) vehicle treatment eyelash hypotrichosis ( inadequate eyelash ) .</brief_summary>
	<brief_title>Bimatoprost Treatment Eyelash Hypotrichosis</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Male female adult patient eyelash hypotrichosis ( inadequate eyelash growth ) . Damage eyelid area ( scar ) may prevent growth eyelash Active eye disease ( glaucoma , uveitis , eye infection , chronic blepharitis severe dry eye ) Eye eyelid surgery ( include laser , refractive , intraocular filtering surgery , blepharoplasty ) 3 month prior screen Current eyelash implant kind Eyelash tint dye application within 2 month baseline Eyelash extension application within 3 month baseline Use eyelash growth product within 6 month baseline Treatments may affect hair growth ( minoxidil , cancer chemotherapeutic agent , etc ) within 6 month prior baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>